A model for p53-induced apoptosis
The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
The inactivation of the p53 gene in a large proportion of human cancers has inspired an intense search for the encoded protein's physiological and biological properties. Expression of p53 induces either a stable growth arrest or programmed cell death (apoptosis). In human colorectal cancers, the growth arrest is dependent on the transcriptional induction of the protein p21WAF1/CIP1 , but the mechanisms underlying the development of p53-dependent apoptosis are largely unknown. As the most well documented biochemical property of p53 is its ability to activate transcription of genes, we examined in detail the transcripts induced by p53 expression before the onset of apoptosis. Of 7,202 transcripts identified, only 14 (0.19%) were found to be markedly increased in p53-expressing cells compared with control cells. Strikingly, many of these genes were predicted to encode proteins that could generate or respond to oxidative stress, including one that is implicated in apoptosis in plant meristems. These observations stimulated additional biochemical and pharmacological experiments suggesting that p53 results in apoptosis through a three-step process: (1) the transcriptional induction of redox-related genes; (2) the formation of reactive oxygen species; and (3) the oxidative degradation of mitochondrial components, culminating in cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, activation of the major downstream effectors of the DDR/senescence checkpoint can induce ROS production (Polyak et al, 1997; Macip et al, 2002, 2003).”
From Feedback between p21 and reactive oxygen production is necessary for cell senescence (2010) · cites this paper as Polyak et al, 1997
In the citing paper
“If the cell contains mutant p53, APR-246 will reactivate mutant p53 and induce pro-apoptotic p53 target genes, which may lead to a further increase in ROS37.”
From Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246 (2018) · cites this paper as [37]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Self-citationp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Serial Analysis of Gene Expression
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,711
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Self-citationMitochondrial control of apoptosis
Kroemer, G., Zamzami, N., & Susin, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80014-x · Cited by 1,471
Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., & Kroemer, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1331 · Cited by 1,132
Characterization of the Yeast Transcriptome
Velculescu, V. E., Zhang, L., Zhou, W., Vogelstein, J., Basrai, M. A., Bassett, D. E., Hieter, P., Vogelstein, B., & Kinzler, K. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81845-0 · Cited by 973
Self-citation
Cited by
Items 401–500 of 1,008
Lorenzo, E., Ruiz‐Ruiz, C., Quesada, A. J., Hernández, G., Rodríguez, A., López‐Rivas, A., & Redondo, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107442200 · Cited by 170
Wickremasinghe, R. G., & Hoffbrand, A. V. (1999) · Blood · doi:10.1182/blood.v93.11.3587 · Cited by 170
Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus
Wu, J., Ding, T., & Sun, J. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2012.09.006 · Cited by 169
Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species
Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., & Kufe, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000099200 · Cited by 169
Functional Consequences of PRODH Missense Mutations
Bender, H., Almashanu, S., Steel, G., Hu, C.-A. A., Lin, W., Willis, A. S., Pulver, A. E., & Valle, D. L. (2005) · The American Journal of Human Genetics · doi:10.1086/428142 · Cited by 169
Henderson, C. J., Mizzau, M., Paroni, G., Maestro, R., Schneider, C., & Brancolini, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213093200 · Cited by 169
Regulation of Apoptosis and Cell Cycle Progression by MCL1
Fujise, K., Zhang, D., Liu, J.-L., & Yeh, E. T. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006626200 · Cited by 168
Gene expression patterns associated with p53 status in breast cancer
Troester, M. A., Herschkowitz, J. I., Oh, D. S., He, X., Hoadley, K. A., Barbier, C. S., & Perou, C. M. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-276 · Cited by 168
Genomic Views of the Immune System
Staudt, L. M., & Brown, P. O. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.829 · Cited by 168
Baptiste, N., Friedlander, P. A., Chen, X., & Prives, C. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205015 · Cited by 168
Human Microsomal Prostaglandin E Synthase-1
Thorén, S., Weinander, R., Saha, S., Jegerschöld, C., Pettersson, P. L., Samuelsson, B., Hebert, H., Hamberg, M., Morgenstern, R., & Jakobsson, P.-J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303227200 · Cited by 167
Matsumura, H., Nirasawa, S., & Terauchi, R. (1999) · The Plant Journal · doi:10.1046/j.1365-313x.1999.00640.x · Cited by 167
p53 and mitochondrial function in neurons
Wang, D. B., Kinoshita, C., Kinoshita, Y., & Morrison, R. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.015 · Cited by 167
Zhang, G., Liu, A., Zhou, Y., San, X., Jin, T., & Jin, Y. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.026 · Cited by 167
Patankar, S., Gunasekera, A. M., Shoaibi, A., Cummings, L. M., & Wirth, D. F. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.10.3114 · Cited by 167
Sawada, M., Nakashima, S., Banno, Y., Yamakawa, H., Hayashi, K., Takenaka, K., Nishimura, Y., Sakai, N., & Nozawa, Y. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400711 · Cited by 167
Transcriptional repression mediated by the p53 tumour suppressor
Ho, J., & Benchimol, S. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401191 · Cited by 166
Mutations in apoptosis genes: a pathogenetic factor for human disease
Müllauer, L., Gruber, P., Sebinger, D., Buch, J., Wohlfart, S., & Chott, A. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00057-6 · Cited by 166
Identification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis
Zhu, J., Zhou, W., Jiang, J., & Chen, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13030 · Cited by 166
Redox signalling and transition metals in the control of the p53 pathway
Méplan, C., Richard, M.-J., & Hainaut, P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00297-x · Cited by 166
Olovnikov, I. A., Kravchenko, J. E., & Chumakov, P. M. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.005 · Cited by 153
JAKOBSSON, P.-J., MORGENSTERN, R., MANCINI, J., FORD-HUTCHINSON, A., & PERSSON, B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-5 · Cited by 165
Arrest of spermatogenesis in mice expressing an active heat shock transcription factor 1
Nakai, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1545 · Cited by 165
15-Deoxy-Δ 12,14 -prostaglandin J 2 : The endogenous electrophile that induces neuronal apoptosis
Kondo, M., Shibata, T., Kumagai, T., Osawa, T., Shibata, N., Kobayashi, M., Sasaki, S., Iwata, M., Noguchi, N., & Uchida, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112212599 · Cited by 165
Stephenson, A. J., Smith, A., Kattan, M. W., Satagopan, J., Reuter, V. E., Scardino, P. T., & Gerald, W. L. (2005) · Cancer · doi:10.1002/cncr.21157 · Cited by 164
Regulation and function of proline oxidase under nutrient stress
Pandhare, J., Donald, S. P., Cooper, S. K., & Phang, J. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22174 · Cited by 164
Tomasini, R., Samir, A. A., Carrier, A., Isnardon, D., Cecchinelli, B., Soddu, S., Malissen, B., Dagorn, J.-C., Iovanna, J. L., & Dusetti, N. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301979200 · Cited by 164
Carlile, G. W., Chalmers-Redman, R. M. E., Tatton, N. A., Pong, A., Borden, K. L. B., & Tatton, W. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26436-1 · Cited by 164
Fico, A., Paglialunga, F., Cigliano, L., Abrescia, P., Verde, P., Martini, G., Iaccarino, I., & Filosa, S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401420 · Cited by 164
RetractedEssential Role for Caspase-8 in Transcription-independent Apoptosis Triggered by p53
Ding, H., Lin, Y., McGill, G. G., Juo, P., Zhu, H., Blenis, J., Yuan, J., & Fisher, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004714200 · Cited by 167
Involvement of p85 in p53-dependent apoptotic response to oxidative stress
Yin, Y., Terauchi, Y., Solomon, G. G., Aizawa, S., Rangarajan, P. N., Yazaki, Y., Kadowaki, T., & Barrett, J. C. (1998) · Nature · doi:10.1038/35648 · Cited by 164
Crystal Structure of a Superstable Mutant of Human p53 Core Domain
Joerger, A. C., Allen, M. D., & Fersht, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309732200 · Cited by 163
Proline Metabolism in Tumor Growth and Metastatic Progression
D'Aniello, C., Patriarca, E. J., Phang, J. M., & Minchiotti, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00776 · Cited by 163
Drosophila p53 preserves genomic stability by regulating cell death
Sogame, N., Kim, M., & Abrams, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736384100 · Cited by 163
Mitochondrial Membrane Permeabilization during the Apoptotic Process
JACOTOT, E., COSTANTINI, P., LABOUREAU, E., ZAMZAMI, N., SUSIN, S. A., & KROEMER, G. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07919.x · Cited by 145
Immunogenetics of Hashimoto's thyroiditis
Chistiakov, D. A. (2005) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-2-1 · Cited by 162
Mitochondria as targets for cancer chemotherapy
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.007 · Cited by 162
Mahyar-Roemer, M., & Roemer, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204440 · Cited by 162
Caught in the cross fire: p53 in inflammation
Cooks, T., Harris, C. C., & Oren, M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu134 · Cited by 162
Bioinformatic and enzymatic characterization of the MAPEG superfamily
Bresell, A., Weinander, R., Lundqvist, G., Raza, H., Shimoji, M., Sun, T., Balk, L., Wiklund, R., Eriksson, J. W., Jansson, C., et al. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04596.x · Cited by 162
Li, Y., Zhu, H., & Trush, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00040-9 · Cited by 145
The Proline Regulatory Axis and Cancer
Phang, J. M., Liu, W., Hancock, C., & Christian, K. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00060 · Cited by 161
Potential Applications of NRF2 Modulators in Cancer Therapy
Panieri, E., Buha, A., Telkoparan-Akillilar, P., Cevik, D., Kouretas, D., Veskoukis, A., Skaperda, Z., Tsatsakis, A., Wallace, D., Suzen, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030193 · Cited by 161
Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA
Kim, J.-S., Lee, C., Bonifant, C. L., Ressom, H., & Waldman, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00537-06 · Cited by 161
Mechanisms of Iron Porphyrin Reactions with Peroxynitrite
Lee, J., Hunt, J. A., & Groves, J. T. (1998) · Journal of the American Chemical Society · doi:10.1021/ja980507y · Cited by 161
Natarajan, S. K., Zhu, W., Liang, X., Zhang, L., Demers, A. J., Zimmerman, M. C., Simpson, M. A., & Becker, D. F. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.002 · Cited by 148
MacLachlan, T. K., Takimoto, R., & El-Deiry, W. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4280-4292.2002 · Cited by 160
Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
Shi, T., & Dansen, T. B. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8074 · Cited by 160
Transcription, apoptosis and p53: catch-22
SCHULER, M., & GREEN, D. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.01.001 · Cited by 160
miR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y.-H., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 160
The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
Rivera, A., & Maxwell, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504852200 · Cited by 160
Influenza Virus Infection Increases p53 Activity: Role of p53 in Cell Death and Viral Replication
Turpin, E., Luke, K., Jones, J., Tumpey, T., Konan, K., & Schultz-Cherry, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8802-8811.2005 · Cited by 160
Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53
Wang, J., Shou, J., & Chen, X. (2000) · Oncogene · doi:10.1038/sj.onc.1203503 · Cited by 159
Early stages of p53-induced apoptosis are reversible
Geske, F. J., Lieberman, R., Strange, R., & Gerschenson, L. E. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400786 · Cited by 159
Wick, W., Grimmel, C., Wagenknecht, B., Dichgans, J., & Weller, M. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38274-6 · Cited by 144
Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting
Nagy, N., Legendre, H., Engels, O., André, S., Kaltner, H., Wasano, K., Zick, Y., Pector, J., Decaestecker, C., Gabius, H., et al. (2003) · Cancer · doi:10.1002/cncr.11268 · Cited by 159
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death
Wischhusen, J., Naumann, U., Ohgaki, H., Rastinejad, F., & Weller, M. (2003) · Oncogene · doi:10.1038/sj.onc.1207198 · Cited by 158
“…cell death involves epiphenomenal free radical formation, is inhibited by aurintricarboxylic acid (ATA) and may be mediated by calcium cytotoxicity Free radical formation has been linked to p53-dependent and p53-independent types of cell death (Lotem et al., 1996; Polyak et al., 1997).”
Backgroundp53-dependent cell death signaling in neurons
Morrison, R. S., Kinoshita, Y., Johnson, M. D., Guo, W., & Garden, G. A. (2003) · Neurochemical Research · doi:10.1023/a:1021687810103 · Cited by 158
Ribeiro, A., Bronk, S. F., Roberts, P. J., Urrutia, R., & Gores, G. J. (1999) · Hepatology · doi:10.1002/hep.510300620 · Cited by 158
Galectins as Molecular Targets for Therapeutic Intervention
Dings, R. P. M., Miller, M. C., Griffin, R. J., & Mayo, K. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030905 · Cited by 158
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157
“In an attempt to explain the mechanisms of the pro-apoptotic activity of p53, several targets named PIG1–13 (p53-inducible genes 1–13) with strong pro-oxidant properties were described (Polyak et al., 1997).”
Backgroundp53 regulates mtDNA copy number and mitocheckpoint pathway
Singh, K., Kulawiec, M., & Ayyasamy, V. (2009) · Journal of Carcinogenesis · doi:10.4103/1477-3163.50893 · Cited by 137
Molecular Pathogenesis of Non-Hodgkin's Lymphoma: the Role of Bcl-6
Pasqualucci, L., Bereshchenko, O., Niu, H., Klein, U., Basso, K., Guglielmino, R., Cattoretti, G., & Dalla-Favera, R. (2003) · Leukemia & Lymphoma · doi:10.1080/10428190310001621588 · Cited by 138
Kopitz, J., André, S., Reitzenstein, C., Versluis, K., Kaltner, H., Pieters, R. J., Wasano, K., Kuwabara, I., Liu, F., Cantz, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206631 · Cited by 157
Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily
Yang, R., Hsu, D. K., Yu, L., Ni, J., & Liu, F. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010914200 · Cited by 157
Molecular mechanisms of ionizing radiation‐induced apoptosis
Watters, D. J. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00824.x · Cited by 155
Regulation of cellular homeostasis by galectins
Hsu, D. K., & Liu, F. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014080.95829.52 · Cited by 156
Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., Wu, G., Nomoto, S., Trink, B., & Sidransky, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6077-6089.2005 · Cited by 134
SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents
Duan, H., Wang, Y., Aviram, M., Swaroop, M., Loo, J. A., Bian, J., Tian, Y., Mueller, T., Bisgaier, C. L., & Sun, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3145 · Cited by 156
Abbas, H. A., Maccio, D. R., Coskun, S., Jackson, J. G., Hazen, A. L., Sills, T. M., You, M. J., Hirschi, K. K., & Lozano, G. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.013 · Cited by 142
Burns, T. F., Bernhard, E. J., & El‐Deiry, W. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204484 · Cited by 155
Latonen, L., Taya, Y., & Laiho, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204883 · Cited by 155
The p53 network in lung carcinogenesis
Robles, A. I., Linke, S. P., & Harris, C. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205563 · Cited by 154
Caspases disrupt mitochondrial membrane barrier function
Marzo, I., Susín, S. A., Petit, P. X., Ravagnan, L., Brenner, C., Larochette, N., Zamzami, N., & Kroemer, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00424-4 · Cited by 153
The Multifaceted Roles of Proline in Cell Behavior
Patriarca, E. J., Cermola, F., D’Aniello, C., Fico, A., Guardiola, O., Cesare, D. D., & Minchiotti, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728576 · Cited by 153
Adnane, J., Bizouarn, F. A., Qian, Y., Hamilton, A. D., & Sebti, S. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6962 · Cited by 141
The Y-box-binding Protein, YB1, Is a Potential Negative Regulator of the p53 Tumor Suppressor
Lasham, A., Moloney, S., Hale, T. K., Homer, C. R., Zhang, Y. F., Murison, J. G., Braithwaite, A. W., & Watson, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303920200 · Cited by 152
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 152
Tumor galectinology: Insights into the complex network of a family of endogenous lectins
Lahm, H., André, S., Hoeflich, A., Kaltner, H., Siebert, H., Sordat, B., von der Lieth, C., Wolf, E., & Gabius, H. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000025817.24297.17 · Cited by 150
Mitochondrial oxidative burst involved in apoptotic response in oats
Yao, N., Tada, Y., Sakamoto, M., Nakayashiki, H., Park, P., Tosa, Y., & MAYAMA, S. (2002) · The Plant Journal · doi:10.1046/j.1365-313x.2002.01314.x · Cited by 150
Campomenosi, P., Monti, P., Aprile, A., Abbondandolo, A., Frébourg, T., Gold, B. I., Crook, T., Inga, A., Resnick, M. A., Iggo, R. D., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204468 · Cited by 150
Tumor Suppressor p53 Inhibits Autoimmune Inflammation and Macrophage Function
Zheng, S.-J., Lamhamedi-Cherradi, S.-E., Wang, P., Xu, L., & Chen, Y. H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1423 · Cited by 141
Meng, R. D., & El‐Deiry, W. S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5073 · Cited by 150
The PP2A-Associated Protein α4 Is an Essential Inhibitor of Apoptosis
Kong, M., Fox, C. J., Mu, J., Solt, L., Xu, A., Cinalli, R. M., Birnbaum, M. J., Lindsten, T., & Thompson, C. B. (2004) · Science · doi:10.1126/science.1100537 · Cited by 149
Another fork in the road—life or death decisions by the tumour suppressor p53
Carvajal, L. A., & Manfredi, J. J. (2013) · The EMBO Reports · doi:10.1038/embor.2013.25 · Cited by 149
p53 and Tumor Necrosis Factor α Regulate the Expression of a Mitochondrial Chloride Channel Protein
Fernández‐Salas, E., Sagar, M., Cheng, C., Yuspa, S. H., & Weinberg, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36488 · Cited by 149
GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth
Zhang, X., Huang, Q., Yang, Z., Li, Y., & Li, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3443 · Cited by 149
Ceccarelli, S., Panera, N., Mina, M., Gnani, D., De Stefanis, C., Crudele, A., Rychlicki, C., Petrini, S., Bruscalupi, G., Agostinelli, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5163 · Cited by 140
Molecular cloning and characterization of chicken lipopolysaccharide-induced TNF-α factor (LITAF)
Hong, Y. H., Lillehoj, H. S., HYENLEE, S., WOONPARK, D., & Lillehoj, E. P. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.12.007 · Cited by 148
Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem, V. W., van den Doel, P. B., Grill, J., Pinedo, H. M., & Gerritsen, W. R. (2002) · PubMed · Cited by 152
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Shizukuda, Y., Matoba, S., Mian, O. Y., Nguyen, T., & Hwang, P. M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-5905-8 · Cited by 148
The critical role of catalase in prooxidant and antioxidant function of p53
Kang, M. Y., Kim, H.-B., Piao, C., Lee, K. K., Hyun, J. W., Chang, I.-Y., & You, H. J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.102 · Cited by 147
Oxygen toxicity: cellular mechanisms in normobaric hyperoxia
Alva, R., Mirza, M., Baiton, A., Lazuran, L., Samokysh, L., Bobinski, A. R., Cowan, C., Jaimon, A., Obioru, D., Makhoul, T. A., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09773-7 · Cited by 148
Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia
Kolb, J. P. (2000) · Leukemia · doi:10.1038/sj.leu.2401896 · Cited by 147
Molecular Phenotype of the Human Oocyte by PCR–SAGE
Neilson, L. I., Andalibi, A., Kang, D., Coutifaris, C., Strauss, J. F., Stanton, J. L., & Green, D. P. L. (2000) · Genomics · doi:10.1006/geno.1999.6059 · Cited by 147
Zheng, P., Chen, Q., Tian, X., Qian, N., Chai, P., Liu, B., Hu, J., Blackstone, C. D., Zhu, D., Teng, J., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0065-z · Cited by 146
Glutathione and glutathione-dependent enzymes in cancer drug resistance
McLellan, L. I., & Wolf, C. R. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0083 · Cited by 146
Pani, G., Bedogni, B., Anzevino, R., Colavitti, R., Palazzotti, B., Borrello, S., & Galeotti, T. (2000) · PubMed · Cited by 145
Proline dehydrogenase: a key enzyme in controlling cellular homeostasis
Servet, C., Ghélis, T., Richard, L., Zilberstein, A., & Savouré, A. (2011) · Frontiers in bioscience · doi:10.2741/3947 · Cited by 145
p53 Is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral Sclerosis
Martin, L. J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0314 · Cited by 135
Metadata
- Authors
- Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1997-09
- Volume
- 389
- Issue
- 6648
- Pages
- 300-305
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1657827244
- Cited by
- 2,500
- References
- 32
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 29 · 2023: 50 · 2022: 44 · 2021: 59 · 2020: 50 · 2019: 38 · 2018: 56 · 2017: 44 · 2016: 58 · 2015: 57 · 2014: 64 · 2013: 66 · 2012: 66
- FWCI
- 82.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- p53, apoptosis, p53-dependent transcription, oxidative stress, reactive oxygen species, mitochondrial degradation, colorectal cancer, p21, growth arrest, transcriptional induction
- MeSH terms
- Amino Acid Sequence, Animals, Gene Expression Regulation, Mitochondria, Molecular Sequence Data, Oxidation-Reduction, Proteins, Time Factors, Transcription, Genetic, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Apoptosis, Reactive Oxygen Species, Sequence Homology, Amino Acid, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.